Skip to main content
Log in

Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses

Analysis of the INTRASTENT multicentric registry

  • Interventional Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

Using balloon-expandable stents (BES) for treatment of intracranial stenoses, high inflation pressures and rigidity of the device are regarded as major drawbacks limiting feasibility and safety of the procedure. Self-expanding stents (SES) were developed to facilitate lesion access and to allow for less aggressive dilatation. We analyzed data of the INTRASTENT multicentric registry to assess whether self-expanding stents significantly reduced peri-interventional complication rates.

Methods

Records of intracranial stent procedures were entered consecutively into the registry. Datasets were divided into two groups according to the type of stent used. For outcome measurement, we chose three categories: TIA/minor stroke [modified Rankin score (mRS) <2], disabling stroke, and patient death. Clinical outcome was compared between BES and SES. We analyzed types of adverse events occurring in each group in addition.

Results

Of 409 atherosclerotic lesions, 254 were treated with BES and 155 with SES. Technical success rates were 97.6% and 98.7%, respectively. Adverse event rates were 4.9%, 3.7%, and 0.8% for TIA/nondisabling stroke, disabling stroke, and death in the BES group compared with 5.3%, 6.0%, and 4.0% in the SES group. The differences were not statistically significant. We observed more perforator strokes after use of BES, but thromboembolic events occurred more often in the SES treatment group.

Conclusion

Data of the INTRASTENT registry do not support the hypothesis that introduction of SES lowered the overall complication rate of intracranial stent procedures. There might be an advantage using self-expanding stents in vessel segments with important perforating arteries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG (2005) Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352:1305–1316

    Article  PubMed  CAS  Google Scholar 

  2. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563

    Article  PubMed  Google Scholar 

  3. Meyers PM, Schumacher CH, Tanji K, Higashida RT, Caplan LR (2007) Use of stents to treat intracranial cerebrovascular disease. Annu Rev Med 58:107–122

    Article  PubMed  CAS  Google Scholar 

  4. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N (2007) Comparison of elective stenting of severe versus moderate intracranial atherosclerotic stenosis. Neurology 68:420–426

    Article  PubMed  CAS  Google Scholar 

  5. Vajda Z, Miloslavski E, Güthe T, Schmid E, Schul C, Albes G, Henkes H (2009) Treatment of intracranial atherosclerotic arterial stenoses with a balloon-expandable cobalt chromium stent (Coroflex Blue). Neuroradiology. doi:10.1007/s00234-009-0615-7

    PubMed  Google Scholar 

  6. Jiang WJ, Xu XT, Jin M, Du B, Dong KH, Dai JP (2007) Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results. Am J Neuroradiol 28:830–834

    PubMed  Google Scholar 

  7. Lylyk P, Rufenacht D, Ferrario A, Miranda C, Pabon B, Mussachio A, Vila JF, Cohen JE (2005) Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 27(Suppl 1):S84–S88

    Article  PubMed  Google Scholar 

  8. Kurre W, Berkefeld J, Sitzer M, Neumann-Haefelin T, du Mesnil de Rochemont R (2008) Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable pharos stent: initial experience. Neuroradiology 50:701–708

    Article  PubMed  CAS  Google Scholar 

  9. Fiorella D, Chow M, Anderson M, Woo H, Rasmussen PA, Masaryk TJ (2007) A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar atheromatous disease. Neurosurgery 61:236–243

    Article  PubMed  Google Scholar 

  10. Bose A, Hartmann M, Henkes H, Liu HM, Teng M, Szikora I, Berlis A, Reul J, Yu S, Forsting M, Lui M, Lim W, Po Sit S (2007) A novel self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan Study. Stroke 38:1531–1537

    Article  PubMed  CAS  Google Scholar 

  11. Henkes H, Milosawski E, Lowens S, Reinartz J, Liebig T, Kühne D (2004) Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (wingspan). Neuroradiology 47:222–228

    Article  Google Scholar 

  12. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienietz B, Hanel RA, Woo H, Radmussen PA, Hopkins LN, Masaryk TJ, McDougall CG (2007) US multicenter experience with the wingspan stent system for treatment of intracranial atherosclerotic disease—periprocedural results. Stroke 38:881–887

    Article  PubMed  Google Scholar 

  13. Kurre W, Berkefeld J, Brassel F, Brüning R, Eckert B, Kamek S, Klein GE, Knauth M, Liebig T, Maskova J, Mucha D, Neumann-Haefelin T, Pilgram-Pastor S, Sitzer M, Sonnberger M, Tietke M, Trenkler J, Turowski B, INTRASTENT Study Group (2010) In hospital complication rates after stent treatment of 388 intracranial stenoses—results from the INTRASTENT multicentric registry. Stroke 41:494–498

    Article  PubMed  Google Scholar 

  14. Berry CC (1990) A tutorial in confidence intervals for proportions in diagnostic radiology. AJR 154:477–480

    PubMed  CAS  Google Scholar 

  15. Mori T, Kazita K, Chokyu K, Mima T, Mori K (2000) Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 21:249–254

    PubMed  CAS  Google Scholar 

  16. Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Chimowitz MI, NIH Multicenter Wingspan Intracranial Stent Registry Study Group (2009) Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 72:2014–2019

    Article  PubMed  CAS  Google Scholar 

  17. Jiang WJ, Srivastava T, Gao F, Du B, Dong KH, Xu XT (2006) Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 66:1868–1872

    Article  PubMed  CAS  Google Scholar 

  18. Müller-Schunk S, Linn J, Peters N, Spannagl M, Deisenberg M, Brückmann H, Mayer TE (2008) Monitoring of clopidogrel-related platelet inhibition: correlation of nonresponse with clinical outcome in supra-aortic stenting. AJNR Am J Neuroradiol 29:786–791

    Article  PubMed  Google Scholar 

  19. Prabhrakan S, Wells KR, Lee VH, Flaherty CA, Lopes DK (2007) Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. Am J Neuroradiol 29:281–285

    Article  Google Scholar 

Download references

Acknowledgments

We thank the collaborators of the INTRASTENT study group.

In Germany:

From the University of Frankfurt, we thank W. Kurre, J. Berkefeld, M. Sitzer, T. Neumann-Haefelin, and M. Lorenz; from the University of Göttingen, M. Knauth, S. Pilgram-Pastor, R. Schramm, and J.H. Buhk; from AK Altona Hamburg, B. Eckert, A. Leppien; from the Asklepios Klinik Barmbek Hamburg, R. Brüning and T. Fitting; from the University of Hamburg, J. Fiehler and O. Wittkugel; from the University of Düsseldorf, B. Turowski; from the University of Dresden, R. v. Kummer, D. Mucha, and V. Pütz; from the University of Kiel, O. Jansen, and M. Tietke; from Wedau Kliniken Duisburg, F. Brassel, D. Meila, and S. Schotes; from the University of Mainz, W. Müller-Forell; from the University Hospital Rechts der Isar Munich, Th. Liebig, and F. Dorn; from the University of Marburg, I. Kureck; and from Helios Klinikum Erfurt, J. Klisch and V. Sychra.

In Austria:

From Landesnervenklinik Wagner-Jauregg Linz, we thank J. Trenkler, M. Sonnberger, and H.P. Haring; and University of Graz, G.E. Klein, T. Mikolits, K. Niederkorn, and S. Horner.

In Great Britain:

From the University of Oxford, we thank W. Kueker.

In Greece:

From the Papanikolaou General Hospital Thessaloniki, we thank V. Katsaridis.

In Czechoslovakia:

From the Central Military Hospital Prague, we thank J. Maskova and H. Parobkova.

Conflict of interest

W. Kurre has received a modest Speaker's Honoraria from Micrus Endovascular. J. Berkefeld has received modest honoraria as a Consultant of Micrus Endovascular. B. Eckert has received modest Speaker's honoraria from Boston Scientific.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Wiebke Kurre.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurre, W., Brassel, F., Brüning, R. et al. Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses. Neuroradiology 54, 43–50 (2012). https://doi.org/10.1007/s00234-010-0826-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-010-0826-y

Keywords

Navigation